Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells

European Journal of Nutrition

Volumn 54, Issue 2, 2015, Pages 265-272

  Tran, Anh Thu ^a   Ramalinga, Malathi ^a   Kedir, Habib ^a   Clarke, Robert ^b   Kumar, Deepak ^a,b  

^a UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Autophagy; Breast cancer; Tocomin ; Tocotrienols; Vitamin E

Indexed keywords

3-METHYLADENINE; ADENINE; ALPHA TOCOTRIENOL; ANTINEOPLASTIC ANTIMETABOLITE; ANTIOXIDANT; TOCOMIN;

ADVERSE EFFECTS; AGONISTS; ANALOGS AND DERIVATIVES; APOPTOSIS; BREAST NEOPLASMS; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; HUMAN; MAMMARY GLAND; METABOLISM; TUMOR CELL LINE;

ADENINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIOXIDANTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DIETARY SUPPLEMENTS; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; TOCOTRIENOLS;

EID: 84939877243     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0707-y     Document Type: Article

References (47)

1. Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Canali R, Virgili F (2004) Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann NY Acad Sci 1031:143–157
2. Komiyama K, Iizuka K, Yamaoka M, Watanabe H, Tsuchiya N, Umezawa I (1989) Studies on the biological activity of tocotrienols. Chem Pharm Bull (Tokyo) 37(5):1369–1371
3. Sen CK, Khanna S, Rink C, Roy S (2007) Tocotrienols: the emerging face of natural vitamin E. Vitam Horm 76:203–261
4. Noguchi N, Hanyu R, Nonaka A, Okimoto Y, Kodama T (2003) Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alpha-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34(12):1614–1620
5. Srivastava JK, Gupta S (2006) Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346(2):447–453
6. Sakai M, Okabe M, Yamasaki M, Tachibana H, Yamada K (2004) Induction of apoptosis by tocotrienol in rat hepatoma dRLh-84 cells. Anticancer Res 24(3a):1683–1688
7. Ling MT, Luk SU, Al-Ejeh F, Khanna KK (2011) Tocotrienol as a potential anticancer agent. Carcinogenesis. doi:10.1093/carcin/bgr261
8. Nesaretnam K, Meganathan P, Veerasenan SD, Selvaduray KR (2012) Tocotrienols and breast cancer: the evidence to date. Genes Nutr 7(1):3–9. doi:10.1007/s12263-011-0224-z
9. Sylvester PW, Wali VB, Bachawal SV, Shirode AB, Ayoub NM, Akl MR (2012) Tocotrienol combination therapy results in synergistic anticancer response. Front Biosci: J Virtual Libr 17:3183–3195
10. Kannappan R, Gupta SC, Kim JH, Aggarwal BB (2012) Tocotrienols fight cancer by targeting multiple cell signaling pathways. Genes Nutr 7(1):43–52. doi:10.1007/s12263-011-0220-3
11. de Mesquita ML, Araujo RM, Bezerra DP, Filho RB, de Paula JE, Silveira ER, Pessoa C, de Moraes MO, Costa Lotufo LV, Espindola LS (2011) Cytotoxicity of delta-tocotrienols from Kielmeyera coriacea against cancer cell lines. Bioorg Med Chem 19(1):623–630. doi:10.1016/j.bmc.2010.10.044
12. Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, Lee TK, Vasireddy RS, Wong YC, Ching YP, Nelson C, Yap YL, Ling MT (2011) Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer 128(9):2182–2191. doi:10.1002/ijc.25546
13. Taridi NM, Yahaya MF, Teoh SL, Latiff AA, Ngah WZ, Das S, Mazlan M (2011) Tocotrienol rich fraction (TRF) supplementation protects against oxidative DNA damage and improves cognitive functions in Wistar rats. La Clinica terapeutica 162(2):93–98
14. Ren Z, Pae M, Dao MC, Smith D, Meydani SN, Wu D (2010) Dietary supplementation with tocotrienols enhances immune function in C57BL/6 mice. J Nutr 140(7):1335–1341. doi:10.3945/jn.110.121434
15. Hafid SR, Radhakrishnan AK, Nesaretnam K (2010) Tocotrienols are good adjuvants for developing cancer vaccines. BMC Cancer 10:5. doi:10.1186/1471-2407-10-5
16. Shah SJ, Sylvester PW (2005) Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood) 230(4):235–241
17. Shah S, Sylvester PW (2004) Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp Biol Med (Maywood) 229(8):745–755
18. Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K (2011) Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med 51(6):1164–1174. doi:10.1016/j.freeradbiomed.2011.06.008
19. Katuru R, Fernandes NV, Elfakhani M, Dutta D, Mills N, Hynds DL, King C, Mo H (2011) Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. Exp Biol Med 236(5):604–613. doi:10.1258/ebm.2011.010379
20. Elangovan S, Hsieh TC, Wu JM (2008) Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res 28(5A):2641–2647
21. Loganathan R, Selvaduray KR, Nesaretnam K, Radhakrishnan AK (2013) Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity. Cell Prolif 46(2):203–213. doi:10.1111/cpr.12014
22. Gopalan A, Yu W, Jiang Q, Jang Y, Sanders BG, Kline K (2012) Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells. Mol Nutr Food Res 56(12):1803–1811. doi:10.1002/mnfr.201200350
23. Liu HK, Wang Q, Li Y, Sun WG, Liu JR, Yang YM, Xu WL, Sun XR, Chen BQ (2010) Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem 21(3):206–213. doi:10.1016/j.jnutbio.2008.11.004
24. Xu YW, Wang B, Ding CH, Li T, Gu F, Zhou C (2011) Differentially expressed micoRNAs in human oocytes. J Assist Reprod Genet 28(6):559–566. doi:10.1007/s10815-011-9590-0
25. Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Reimann K, Razak G, Virgili F (2004) Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 39(5):459–467
26. Takahashi K, Loo G (2004) Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem Pharmacol 67(2):315–324
27. Constantinou C, Neophytou CM, Vraka P, Hyatt JA, Papas KA, Constantinou AI (2011) Induction of DNA damage and caspase-independent programmed cell death by Vitamin E. Nutr Cancer. doi:10.1080/01635581.2012.630167
28. Agarwal MK, Agarwal ML, Athar M, Gupta S (2004) Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3(2):205–211
29. Patacsil D, Tran AT, Cho YS, Suy S, Saenz F, Malyukova I, Ressom H, Collins SP, Clarke R, Kumar D (2012) Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells. J Nutr Biochem 23(1):93–100. doi:10.1016/j.jnutbio.2010.11.012
30. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E, Momoi T (2007) ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14(2):230–239. doi:10.1038/sj.cdd.4401984
31. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K, Shiosaka S, Hammarback JA, Urano F, Imaizumi K (2006) Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26(24):9220–9231. doi:10.1128/MCB.01453-06
32. Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, van der Kogel AJ, Koritzinsky M, Wouters BG (2010) The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Investig 120(1):127–141. doi:10.1172/JCI40027
33. Lee H, Noh JY, Oh Y, Kim Y, Chang JW, Chung CW, Lee ST, Kim M, Ryu H, Jung YK (2012) IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. Hum Mol Genet 21(1):101–114. doi:10.1093/hmg/ddr445
34. Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ, Fan J (2011) Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 7(10):1159–1172. doi:10.4161/auto.7.10.16818
35. Nishikawa T, Tsuno NH, Okaji Y, Shuno Y, Sasaki K, Hongo K, Sunami E, Kitayama J, Takahashi K, Nagawa H (2010) Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann Surg Oncol 17(2):592–602. doi:10.1245/s10434-009-0696-x
36. Carew JS, Medina EC, Esquivel JA 2nd, Mahalingam D, Swords R, Kelly K, Zhang H, Huang P, Mita AC, Mita MM, Giles FJ, Nawrocki ST (2010) Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med 14(10):2448–2459. doi:10.1111/j.1582-4934.2009.00832.x
37. Livesey KM, Tang D, Zeh HJ, Lotze MT (2009) Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 10(12):1269–1279
38. Ren Y, Huang F, Liu Y, Yang Y, Jiang Q, Xu C (2009) Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep 42(9):599–604
39. Hou YJ, Dong LW, Tan YX, Yang GZ, Pan YF, Li Z, Tang L, Wang M, Wang Q, Wang HY (2011) Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma. Lab Invest 91(8):1146–1157. doi:10.1038/labinvest.2011.97
40. Xie BS, Zhao HC, Yao SK, Zhuo DX, Jin B, Lv DC, Wu CL, Ma DL, Gao C, Shu XM, Ai ZL (2011) Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med 27(4):599–606. doi:10.3892/ijmm.2011.607
41. Chen LH, Loong CC, Su TL, Lee YJ, Chu PM, Tsai ML, Tsai PH, Tu PH, Chi CW, Lee HC, Chiou SH (2011) Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochem Pharmacol 81(5):594–605. doi:10.1016/j.bcp.2010.12.011
42. Shibata A, Nakagawa K, Shirakawa H, Kobayashi T, Kawakami Y, Takashima R, Ohashi A, Sato S, Ohsaki Y, Kimura F, Kimura T, Tsuduki T, Komai M, Miyazawa T (2012) Physiological effects and tissue distribution from large doses of tocotrienol in rats. Biosci Biotechnol Biochem 76(9):1805–1808
43. Nesaretnam K, Dorasamy S, Darbre PD (2000) Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. Int J Food Sci Nutr 51(Suppl):S95–S103
44. Nesaretnam K, Stephen R, Dils R, Darbre P (1998) Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33(5):461–469
45. Miyoshi N, Wakao Y, Tomono S, Tatemichi M, Yano T, Ohshima H (2011) The enhancement of the oral bioavailability of gamma-tocotrienol in mice by gamma-cyclodextrin inclusion. J Nutr Biochem 22(12):1121–1126. doi:10.1016/j.jnutbio.2010.09.011
46. Fu JY, Che HL, Tan DM, Teng KT (2014) Bioavailability of tocotrienols: evidence in human studies. Nutr Metab 11(1):5. doi:10.1186/1743-7075-11-5
47. Yap SP, Yuen KH, Wong JW (2001) Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 53(1):67–71